BA
Brijesh Amar Bahadur Singh
About Brijesh Amar Bahadur Singh
Data last updated:
Brijesh Amar Bahadur Singh is a Director at Satyam Generic Pharma Private Limited (since 2000), Director at Prevego Healthcare & Research Private Limited (since 2018) and Director at Sundaram Pharma Private Limited (since 2004), and holds 2 more current directorships. The companies operate in Pharma and Packaging. The 3 current companies with reported revenue have a combined latest revenue of ₹135 Cr; the largest is Satyam Generic Pharma Private Limited at ₹64.48 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Satyam Generic Pharma Private Limited U51397MH2000PTC129773 | Director | 27 Nov 2000 | 2000 | ₹64.48 Cr (FY 2025) | Active |
 Prevego Healthcare & Research Private Limited U74999MH2018PTC309271 | Director | 11 May 2018 | 2018 | ₹64.30 Cr (FY 2024) | Active |
| Sundaram Pharma Private Limited U51397MH2004PTC149475 | Director | 09 Nov 2004 | 2004 | ₹5.79 Cr (FY 2025) | Active |
| Geminova Pharmaceuticals Private Limited U47721MH2025PTC438045 | Director | 14 Jan 2025 | 2025 | Active | |
| Chandra-Corbox Packaging Private Limited U21020MH1997PTC109071 | Director | 30 Jun 1997 | 1997 | Active |
Board colleagues of Brijesh Amar Bahadur Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhroov Dinesh Singh | 09536934 | Satyam Generic Pharma Private Limited , Sundaram Pharma Private Limited | Director |
| Dinesh Amar Bahadur Singh | 00938251 | Satyam Generic Pharma Private Limited , Sundaram Pharma Private Limited and 1 more | Director |
| Hemant Suresh Shah | 07001187 | Prevego Healthcare & Research Private Limited | Director |
| Ketan Mahesh Shah | 02863089 | Prevego Healthcare & Research Private Limited | Additional Director |
| Manoj Suresh Shah | 07001169 | Prevego Healthcare & Research Private Limited | Additional Director |
| Ritesh Shah Suresh | 07001198 | Prevego Healthcare & Research Private Limited | Additional Director |
| Ganpat Ramlakhan Gupta | 09190467 | Geminova Pharmaceuticals Private Limited | Director |
| Amar Bahadur Chandrabali Singh | 00938490 | Chandra-Corbox Packaging Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Brijesh Amar Bahadur Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brijesh Amar Bahadur Singh
Brijesh Amar Bahadur Singh currently holds 5 directorships: Satyam Generic Pharma Private Limited (Director, since 27 Nov 2000, revenue ₹64.48 Cr (FY 2025)); Prevego Healthcare & Research Private Limited (Director, since 11 May 2018, revenue ₹64.30 Cr (FY 2024)); Sundaram Pharma Private Limited (Director, since 09 Nov 2004, revenue ₹5.79 Cr (FY 2025)); Geminova Pharmaceuticals Private Limited (Director, since 14 Jan 2025); Chandra-Corbox Packaging Private Limited (Director, since 30 Jun 1997).
Brijesh Amar Bahadur Singh was first appointed on 30 Jun 1997 as Director at Chandra-Corbox Packaging Private Limited. The most recent appointment on record is 14 Jan 2025 at Geminova Pharmaceuticals Private Limited.
The 3 current companies of Brijesh Amar Bahadur Singh that report revenue have a combined latest revenue of ₹135 Cr: Satyam Generic Pharma Private Limited ₹64.48 Cr (FY 2025); Prevego Healthcare & Research Private Limited ₹64.30 Cr (FY 2024); Sundaram Pharma Private Limited ₹5.79 Cr (FY 2025).
The current boards of Brijesh Amar Bahadur Singh's companies include Dhroov Dinesh Singh (Satyam Generic Pharma Private Limited), Dinesh Amar Bahadur Singh (Satyam Generic Pharma Private Limited), Hemant Suresh Shah (Prevego Healthcare & Research Private Limited), Ketan Mahesh Shah (Prevego Healthcare & Research Private Limited), Manoj Suresh Shah (Prevego Healthcare & Research Private Limited), Ritesh Shah Suresh (Prevego Healthcare & Research Private Limited), among others.